| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |